Obstructive sleep apnea (OSA) is a common disorder where the airway repeatedly becomes blocked during sleep, causing breathing pauses. This leads to poor sleep quality, daytime fatigue, and ...

Sleep apnea can compromise sleep quality, leading to daytime sleepiness, memory issues, and increased long-term health risks, including weight gain. Carrying extra body weight can also increase ...

(Image credit: Getty Images) While in central sleep apnea (CSA), it's down to the central nervous system failing. “The brain fails to tell the muscles of breathing to take a breath, leading to a ...

May 8 (UPI) -- Sleep apnea could be costing you brain power and increasing your risk of dementia and Alzheimer's disease, a new study says. The drop in blood oxygen levels that occurs during a ...

Obstructive sleep apnea, a condition that causes lower oxygen levels during sleep, is linked to degeneration of brain regions associated with memory through damage to the brain's small blood ...

Sleep apnea’s effects extend far beyond increasing the risk of Parkinson’s disease. Untreated OSA has been linked to numerous serious health conditions that affect both quality and length of life.

Sleep apnea is "a common disorder in which breathing is interrupted repeatedly during sleep," Melissa Lipford, M.D., a neurologist at Mayo Clinic, Rochester, previously told USA TODAY.

People with obstructive sleep apnea have an increased risk of Parkinson's disease, but if started early enough, continuous positive airway pressure (CPAP) may reduce that risk, according to a ...

Sleep apnea: What is it, what’s the cause and how to tackle it Three nights of poor sleep can increase your risk of heart disease, study shows ...

StockImageBrasil - stock.adobe.com There’s gouda news for cheese lovers. A recent study found cheese eaters are less likely to have sleep apnea than their dairy-eschewing counterparts.

The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug Administration Dec. 20 press release.